linkedin

Business Continuity Management System (BCMS)

Samsung Biologics is building greater trust with its Business Continuity Management System (BCMS) for clients who are seeking a reliable manufacturing partner to ensure a stable supply of life-saving drugs, especially in light of the current pandemic. ISO22301 is especially meaningful given our critical mission to the biopharma industry to providing patients with a stable supply of life-saving therapies under any circumstances

Business Continuity
Management System
(BCMS, ISO22301)

Samsung Biologics’ holistic management process that identifies potential threats to an organization and the impacts to business operations from such threats; and provides a framework for building organizational resilience with the capability of an effective response that safeguards the interests of its key stakeholders, reputation, brand and value-creating activities.

BuSINESS2020, RISK, BUSINESS RISK, 2020 BUSINESS, RISK BUSINESS BuSINESS2020, RISK, BUSINESS RISK, 2020 BUSINESS, RISK BUSINESS
Purpose of BCMS

Samsung Biologics is operating Business Continuity Management System (BCMS) to protect the assets of our company and clients from risks and to stably deliver key products and services to patients.

Leadership for
BCMS Operation

Samsung Biologics hereby pledges to protect the assets of our company and clients from risk and to stably deliver key products and services to patients to comply with our Business Continuity Management policy.

We strive to identify and evaluate the risk of disruption to Samsung Biologics' activities in order to be a global leading company by implementing processes to prevent and mitigate the impact of disruption through continuous improvement.

We establish a dedicated organization to routinely manage and continually improve suitability, adequacy, and effectiveness throughout the entire whole business continuity management process.

We pledge to be a reliable company for our clients and shareholders by actively participating in BCM activities to stably deliver key products and services.

Samsung Biologics President & CEO
John Rim

ISO22301
  • ISO22301 is a comprehensive standard published by the International Organization for Standardization (ISO) that represents the highest level of commitment to business continuity and disaster preparedness.
  • Samsung Biologics became the first Korean pharmaceutical company to achieve ISO22301 certificate in 2018, and has continuously expanded the scope of certification for ensuring systemic BCMS management.
BCMS Steering
Group

Samsung Biologics has three levels of teams in the response structure. The strategic, tactical, and operational teams in a response structure undertake different activities as follows:

BCMS Steering Group image
BCMS Steering Group image
  • The strategic teams, which focuses on strategic issues that impact the organization's core objectives, products and services, are led by top management. The crisis management team has primary responsibility for addressing any crisis impacting the organization. ※ BCMO: Business Continuity Management Office

  • The tactical teams, which manage and coordinate the continuity of the processes required to deliver the impacted products and services and ensure that the resources are allocated appropriately, are led by a team leader. Tactical level plans provide a framework to coordinate strategic goals and decisions with the operational response teams.

  • The operational teams, which focus on the continuity of the activities that contribute to the processes that deliver the prioritized products and services, is led by each functional site matter expert. An operational response establishes the necessary capability required to continue delivering priotised products and services.

Annual Operation

Embedding BCMS is the ongoing cycle of activities of the business continuity management program, which builds organizational resilience, and is the professional practice that defines how to integrate business continuity awareness and practice into business as usual activities.

BCMS Annual Operational Detail big image
BCMS Annual Operational Detail small image
Analysis
  • - Reviews and assesses an organization to identify our objectives, how it functions and the constrains of its operating environment
    • · Look into environment to find unidentified risks in terms of location, supply chain society, politics and so on.
    • · Internal/external stakeholders
    • · Business Impact Analysis for product, process, activity
Design
  • - Identifies and selects appropriate solutions to determine how continuity can be achieved in the event of an incident
    • · Performing Risk and Threat Mitigation Measures
Implementation
  • - Implements the solutions agreed in the designed stage
    • · Development of Tactical/Operational Business Continuity Strategy
    • · Establishment of Business Continuity Plans & a response structure
Validation
  • - Confirms that the business continuity program meets the objectives set in the policy and the plans and procedures in place are effective.
    • · Exercise Program: performing annual exercises with various types of scenario by each department as well as company-wide
    • · Management Review to ensure it aligns with organizational objectives
BCMS Exercise

Samsung Biologics’ exercise is to train for, assess, practice, and improve performance in an organization to absorb and adapt in a changing environment.
Samsung Biologics’ aim of exercise is to obtain an expected, measureable pass/fail outcome compared to the established plans & scenarios.

  • Crisis Management Committee image

    Crisis Management Committee

  • GMP Document Room Fire Exercise image

    GMP Document Room Fire Exercise

  • Earthquake Exercise image

    Earthquake Exercise

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Subscribe to our newsletter to download.
*If you have already subscribed, enter your email.

뉴스레터 구독 서비스 유무 확인
Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION

Copyright Samsung Biologics. All rights reserved